title: Hypoxia and hypoxia mimetic cooperate to counteract tumor cell resistance to glucose starvation preferentially in tumor cells with mutant p53.
abstract: We demonstrated that exogenous pyruvate promotes survival under glucose depletion in aerobic mutant p53 (R175H) human melanoma cells. Others subsequently indicated that mutant p53 tumor cells undergo p53 degradation and cell death under aerobic glucose-free conditions. Since glucose starvation occurs in hypoxic gradients of poorly vascularized tumors, we investigated the role of p53 siRNA under hypoxia in wt p53 C8161 melanoma using glucose starvation or 5mM physiological glucose. p53 Silencing decreased survival of glucose-starved C8161 melanoma with pyruvate supplementation under hypoxia (≤1% oxygen), but increased resistance to glycolytic inhibitors oxamate and 2-deoxyglucose in 5mM glucose, preferentially under normoxia. Aiming to counteract hypoxic tumor cell survival irrespective of p53 status, genetically-matched human C8161 melanoma harboring wt p53 or mutant p53 (R175H) were used combining true hypoxia (≤1% oxygen) and hypoxia mimetic CoCl2. No significant decrease in metabolic activity was evidenced in C8161 melanoma irrespective of p53 status in 2.5mM glucose after 48h of physical hypoxia. However, combining the latter with 100μM CoCl2 was preferentially toxic for mutant p53 C8161 melanoma, and was enhanced by catalase in wt p53 C8161 cells. Downregulation of MnSOD and LDHA accompanied the toxicity induced by hypoxia and CoCl2 in 5mM glucose, and these changes were enhanced by oxamate or 2-deoxyglucose. Our results show for the first time that survival of malignant cells in a hypoxic microenvironment can be counteracted by hypoxia mimetic co-treatment in a p53 dependent manner.
authors.affiliation: Instituto Venezolano de Investigaciones Científicas (IVIC), CMBC, Tumor Cell Biology Laboratory, Apartado 20632, Caracas 1020A, Venezuela.
authors.forename: Valery A
authors.initials: VA
authors.lastname: Chavez-Perez
authors.affiliation: Instituto Venezolano de Investigaciones Científicas (IVIC), CMBC, Tumor Cell Biology Laboratory, Apartado 20632, Caracas 1020A, Venezuela.
authors.forename: Mary
authors.initials: M
authors.lastname: Strasberg-Rieber
authors.affiliation: Instituto Venezolano de Investigaciones Científicas (IVIC), CMBC, Tumor Cell Biology Laboratory, Apartado 20632, Caracas 1020A, Venezuela. Electronic address: manuel.rieber@gmail.com.
authors.forename: Manuel
authors.initials: M
authors.lastname: Rieber
mesh_terms: D017209:Apoptosis / Q000235:genetics; D015687:Cell Hypoxia; D045744:Cell Line, Tumor; D003035:Cobalt / Q000494:pharmacology; D005947:Glucose / Q000172:deficiency* / Q000494:pharmacology; D006801:Humans; D007770:L-Lactate Dehydrogenase / Q000378:metabolism; D009154:Mutation; D009369:Neoplasms / Q000378:metabolism* / Q000473:pathology*; D010100:Oxygen / Q000378:metabolism*; D011065:Poly(ADP-ribose) Polymerases / Q000378:metabolism; D034741:RNA, Small Interfering / Q000235:genetics; D013482:Superoxide Dismutase / Q000378:metabolism; D016159:Tumor Suppressor Protein p53 / Q000235:genetics
chemical_list: D034741:RNA, Small Interfering; D016159:Tumor Suppressor Protein p53; D003035:Cobalt; D007770:L-Lactate Dehydrogenase; D013482:Superoxide Dismutase; D011065:Poly(ADP-ribose) Polymerases; C018021:cobaltous chloride; D005947:Glucose; D010100:Oxygen
keywords: Hypoxia; LDHA; Oxidative stress; PARP; ROS; Superoxide dismutase; mutant p53 Arg 175His; mutant p53 R175H; p53 Mutation; p53 siRNA; poly(ADP-ribose) polymerase; reactive oxygen species; wild type; wt